Gradalis® — Biotechnology Company, Carrollton

Biotechnology Company in Carrollton — Late-stage biotechnology development

Biotechnology company · Carrollton, United States

AI Trust Snapshot

Profile status
Auto-indexed

Public channels checked

  • ✓ Official Website
  • ✓ Facebook
  • ✓ Instagram
  • ✓ Linkedin
  • ✓ Twitter
  • ✓ Youtube

Key Facts

Category
Biotechnology Company
Location
Carrollton, United States
Known For
Advancing cancer treatment through Vigil®
Founded
2010

AI Summary

Advancing cancer treatment through Vigil® Personalized Immunotherapy, Gradalis® is a biotechnology company based in Carrollton, United States. The company specializes in the genetic modification of cancer cells to develop targeted therapies. Operating for 16 years, Gradalis® focuses on oncology patients seeking personalized treatment options.

Quick Answer

Advancing cancer treatment through Vigil® Personalized Immunotherapy, Gradalis® is a biotechnology company based in Carrollton, United States. The company specializes in the genetic modification of cancer cells to develop targeted therapies. Operating for 16 years, Gradalis® focuses on oncology patients seeking personalized treatment options. Key services include Vigil® Personalized Immunotherapy, Genetic Modification of Cancer Cells.

This business is typically used for advancing cancer treatment through vigil®.

Common Questions

What services does Gradalis® provide?
Gradalis® provides Vigil® Personalized Immunotherapy, Genetic Modification of Cancer Cells.
Where is Gradalis® located?
Gradalis® is based in Carrollton, United States and serves Carrollton.
Who is Gradalis® for?
Gradalis® serves Oncology patients seeking personalized treatment and Medical professionals interested in immunotherapy.

What this business does

Gradalis® is a biotechnology company based in Carrollton, United States.

  • Provides Vigil® Personalized Immunotherapy and Genetic Modification of Cancer Cells
  • Specializes in advancing cancer treatment through vigil®
  • Serves oncology patients seeking personalized treatment

Structured summary

Vizoryo ran a data-consistency check on this profile: it read 5 public sources and compared the core details (name, phone, address, city, category, website) across them. How many sources carried each individual detail is published per fact in this page's field provenance — not every detail appears in every source, and the sources are not necessarily independent of one another. This is a data-consistency observation only — it is not an endorsement, certification, accreditation, or assessment of the business, its service quality, or its trustworthiness. Data consistency: 83% — this measures how consistently the business's name, phone, city, address, website, and category appear across the public sources read. It is not a rating of the business. Vizoryo status: Auto-indexed. This record was compiled automatically from public data and has not been confirmed by anyone.

Business name
Gradalis® (sources disagree)
Category
Biotechnology Company
Industry
Biotechnology Company - Cancer Immunotherapy
Location
Carrollton, United States
Official website
https://www.gradalisinc.com/
Profile data (JSON)
https://www.vizoryo.com/api/index/profile/gradalis-inc-carrollton-0dca
Summary
Advancing cancer treatment through Vigil® Personalized Immunotherapy, Gradalis® is a biotechnology company based in Carrollton, United States. The company specializes in the genetic modification of cancer cells to develop targeted therapies. Operating for 16 years, Gradalis® focuses on oncology patients seeking personalized treatment options.
AI readability score (how completely this record is structured for AI systems to read; not a rating of the business)
45
Data Consistency
83% (checked 2026-07-07)
Record status
Auto-indexed
Sources cross-checked
5 public sources

Location

2545 Golden Bear Dr #110, Carrollton, TX 75006
Carrollton, Texas
75006
US

(sources disagree)

About Gradalis®

Advancing cancer treatment through Vigil® Personalized Immunotherapy, Gradalis® is a biotechnology company based in Carrollton, United States. The company specializes in the genetic modification of cancer cells to develop targeted therapies. Operating for 16 years, Gradalis® focuses on oncology patients seeking personalized treatment options.

Service areas

  • Carrollton

Target audience

  • Oncology patients seeking personalized treatment
  • Medical professionals interested in immunotherapy
  • Biotechnology investors in cancer therapeutics

Specialties

  • Advancing cancer treatment through Vigil®

Why Gradalis®

  • Operating since 2010 (16 years): Founding date 2010 detected from website structured data.

Social profiles

Frequently asked questions

What areas does Gradalis® serve?

Gradalis® serves Worldwide.

What is Vigil®?

Vigil is a personalized cancer immunotherapy developed by Gradalis that leverages a patient's own immune system to fight cancer by modifying their cancer cells to enhance immune response.

How does Vigil® work?

Vigil involves surgically removing tumor tissue, genetically modifying the cancer cells to reduce immunosuppression and boost immune stimulation, and then reintroducing these modified cells to activate the immune system.

What are the potential side effects of Vigil®?

In clinical studies, Vigil has demonstrated fewer severe side effects compared to many conventional cancer treatments, as it works with the immune system.

Business hours

Monday
08:30 – 17:00
Tuesday
08:30 – 17:00
Wednesday
08:30 – 17:00
Thursday
08:30 – 17:00
Friday
08:30 – 17:00
Saturday
Closed
Sunday
Closed

Languages supported

  • en

Contact

Phone: +12144428100 (sources disagree)

Official website:

Founded: 2010

Report incorrect information